Candidature YC de HistoWiz

Winter 2016Active

HistoWiz a été sélectionné par Y Combinator dans le cadre du batch Winter 2016 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Winter 2016
Secteur d'activité: HealthcareHealthcare Services
Taille de l'équipe: 2
Statut: Active
Lancé: 2015

Fondateurs

Ke ChengFounder/CEO

Ce que fait HistoWiz

HistoWiz is an innovative company dedicated to accelerating pathology-based research. HistoWiz provides fast, global access to digital whole-slide images, online collaboration tools, low-cost data management, and experimental pathology expertise. The web-based platform accelerates information exchange among medical scientists and research pathologists. HistoWiz's mission is to fight cancer cooperatively instead of individually by connecting scientists and pathologists for online collaboration. The HistoWiz advantage We help your lab minimize the cost of research and maximize research productivity by providing the most efficient service for scientists to analyze experimental pathology specimens. We believe that scientists should spend their time on results interpretation rather than repetitive tissue cutting. How does it work? HistoWiz accepts formalin-fixed specimens by mail for tissue processing services. To expedite delivery of results and to facilitate global collaboration, HistoWiz offers whole-slide imaging and pathology services, allowing researchers to remotely and instantly view high-magnification images of their specimens via a secure, cloud-based “virtual microscope” on any computer or mobile device without downloading any software or gigabyte-sized files.

Candidature YC de HistoWiz, reconstruite

Candidature Y Combinator

HistoWiz, promotion Winter 2016. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

HistoWiz

Describe what your company does in 50 characters or less.

Accelerating Histopathology for Cancer Research

What is your company going to make? Please describe your product and what it does or will do.

We built a platform that accepts formalin-fixed tissue specimens by mail, processes them for experimental pathology, and provides researchers with secure, cloud-based whole-slide digital images. Our product lets scientists view and collaborate on high-resolution pathology data remotely, speeding up cancer research by cutting down time spent on manual tissue cutting and image sharing.

Where do you live now, and where would the company be based after YC?

We live and work in Brooklyn, NY. After YC, we'll keep the company based here.

Explain your decision regarding location.

Brooklyn has an emerging biotech scene and access to strong research institutions nearby. It's where we live and built our network, so it makes sense to operate from here.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de HistoWiz ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de HistoWiz (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme HistoWiz se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC HistoWiz appartenait-il ?

HistoWiz faisait partie du batch Winter 2016 de Y Combinator.

Qui a fondé HistoWiz ?

HistoWiz a été fondé par Ke Cheng.

Que fait HistoWiz ?

Accelerating Histopathology for Cancer Research

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de HistoWiz en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.